ブックタイトルカテーテル関連尿路感染の予防のためのCDCガイドライン 2009｜株式会社メディコン

概要

カテーテル関連尿路感染の予防のためのCDCガイドライン 2009｜株式会社メディコン

171. Danchaivijitr S, Chokeloidkaew S, Prutsachativuthi S, Trakulsomboon S. Should the open urinary drainagesystem be continued? J Med Assoc Thai. 1988;71 Suppl 3:14-18.172. Wille JC, Blusse van Oud Alblas, A., Thewessen EA. Nosocomial catheter-associated bacteriuria: A clinicaltrial comparing two closed urinary drainage systems. J Hosp Infect. 1993;25(3):191-198.173. Hardyck C, Petrinovich L. Reducing urinary tract infections in catheterized patients. Ostomy Wound.1998;44(12):36-8, 40, 42-3.174. Montagnino BA, Gonzales ET,Jr., Roth DR. Open catheter drainage after urethral surgery. J Urol.1988;140(5):1250-1252.175. Madeo M, Barr B, Owen E. A study to determine whether the use of a pre-connect urinary catheter systemreduces the incidence of nosocomial urinary tract infections. Br J Infect Control. 2005;6(4):22-25.176. Leone M, Garnier F, Dubuc M, Bimar MC, Martin C. Prevention of nosocomial urinary tract infection in ICUpatients: Comparison of effectiveness of two urinary drainage systems. Chest. 2001;120(1):220-224.177. Blenkharn JJ. Prevention of bacteriuria during urinary catheterization of patients in an intensive care unit:Evaluation of the 'ureofix 500' closed drainage system. J Hosp Infect. 1985;6(2):187-193.178. Drach GW, Lacy SS, Cox CE,2 nd . Prevention of catheter-induced post-prostatectomy infection. Effects ofsystemic cephaloridine and local irrigation with neomycin-polymyxin through closed-drainage cathetersystem. J Urol. 1971;105(6):840-842.179. Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of theroutine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections incatheterized patients. J Hosp Infect. 2001;48(1):33-42.180. Platt R, Polk BF, Murdock B, Rosner B. Prevention of catheter-associated urinary tract infection: A costbenefitanalysis. Infect Control Hosp Epidemiol. 1989;10(2):60-64.181. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economicbenefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med.2000;160(17):2670-2675.182. Niel-Weise BS, van den Broek, P. J. Antibiotic policies for short-term catheter bladder drainage in adults.Cochrane Libr. 2006;4.183. Niel-Weise BS, van den Broek, P. J. Urinary catheter policies for long-term bladder drainage. CochraneLibr. 2006;4.184. Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults.Cochrane Libr. 2007(2).185. Esposito S, Noviello S, Leone S, Marvaso A, Drago L, Marchetti F, The LSG. A pilot study on prevention ofcatheter-related urinary tract infections with fluoroquinolones. J Chemother. 2006;18(5):494-501.186. Wazait HD, Patel HR, Van Der Meulen, J. H. P., et al. A pilot randomized double-blind placebo-controlledtrial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: Thepitfalls of ciprofloxacin. BJU Int. 2004;94(7):1048-1050.187. Lukkarinen O, Hellstrom P, Leppilahti M, Kontituri M, Tammela T. Antibiotic prophylaxis in patients withurinary retention undergoing transureteral prostatectomy. Ann Chir Gynaecol. 1997;86(3):239-242.188. Lukkarinen O, Hellstrom P, Leppilahti M, Kontturi M, Tammela T. Prospective randomized open studybetween ciprofloxacin and a combination of sulfadiazine and trimethoprim in antibiotic prophylaxis inconnection with transurethral prostatectomy. Scand J Urol Nephrol. 1996;30(1):33-36.< 参考文献 >109